Satoshi Sakamoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Satoshi Sakamoto has a total of 151 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Handa
Department of Chemical Biology, Tokyo Medical University 4 , Tokyo 160-0023, Japan
9 shared publications- Hiroshi Handa
Department of Molecular Pharmacology, Center for Future Medical Research, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan
8 shared publications Mamoru Hatakeyama
FG Beads Development Section, Biotronics Laboratory, Tamagawa Seiki Co. Ltd, Nagano, Japan
5 shared publicationsYuki Yamaguchi
School of Life Science and Technology, Tokyo Institute of Technology, Yokohama 226-8501, Japan
5 shared publications- Akihiro Kuwahata
Graduate School of Engineering, Tohoku University, Sendai, Japan
4 shared publications Miki Kaneko
Department of Electrical Engineering and Information Systems, Graduate School of Engineering, the University of Tokyo 1 , Tokyo 113-8656, Japan
4 shared publications
Latest Publications
- Open Access
Application of Magnetic Nanoparticles for Rapid Detection and In Situ Diagnosis in Clinical Oncology
Screening, monitoring, and diagnosis are critical in oncology treatment. However, there are limitations with the current clinical methods, notably the time, cost, and special facilities required for radioisotope-based methods. An alternative approach, which uses magnetic beads, offers faster analyses with safer materials over a wide range of oncological applications. Magnetic beads have been used to detect extracellular vesicles (EVs) in the serum of pancreatic cancer patients with statistically different EV levels in preoperative, postoperative, and negative control samples. By incorporating fluorescence, magnetic beads have been used to quantitatively measure prostate-specific antigen (PSA), a prostate cancer biomarker, which is sensitive enough even at levels found in healthy patients. Immunostaining has also been incorporated with magnetic beads and compared with conventional immunohistochemical methods to detect lesions; the results suggest that immunostained magnetic beads could be used for pathological diagnosis during surgery. Furthermore, magnetic nanoparticles, such as superparamagnetic iron oxide nanoparticles (SPIONs), can detect sentinel lymph nodes in breast cancer in a clinical setting, as well as those in gallbladder cancer in animal models, in a surgery-applicable timeframe. Ultimately, recent research into the applications of magnetic beads in oncology suggests that the screening, monitoring, and diagnosis of cancers could be improved and made more accessible through the adoption of this technology.
Open AccessApplication of Magnetic Nanoparticles for Rapid Detection and In Situ Diagnosis in Clinical Oncology
Screening, monitoring, and diagnosis are critical in oncology treatment. However, there are limitations with the current clinical methods, notably the time, cost, and special facilities required for radioisotope-based methods. An alternative approach, which uses magnetic beads, offers faster analyses with safer materials over a wide range of oncological applications. Magnetic beads have been used to detect extracellular vesicles (EVs) in the serum of pancreatic cancer patients with statistically different EV levels in preoperative, postoperative, and negative control samples. By incorporating fluorescence, magnetic beads have been used to quantitatively measure prostate-specific antigen (PSA), a prostate cancer biomarker, which is sensitive enough even at levels found in healthy patients. Immunostaining has also been incorporated with magnetic beads and compared with conventional immunohistochemical methods to detect lesions; the results suggest that immunostained magnetic beads could be used for pathological diagnosis during surgery. Furthermore, magnetic nanoparticles, such as superparamagnetic iron oxide nanoparticles (SPIONs), can detect sentinel lymph nodes in breast cancer in a clinical setting, as well as those in gallbladder cancer in animal models, in a surgery-applicable timeframe. Ultimately, recent research into the applications of magnetic beads in oncology suggests that the screening, monitoring, and diagnosis of cancers could be improved and made more accessible through the adoption of this technology.
- 16 May 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 527 (3) , 668-675
UGGT1 retains proinsulin in the endoplasmic reticulum in an arginine dependent manner
- 16 May 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 527 (3) , 668-675
UGGT1 retains proinsulin in the endoplasmic reticulum in an arginine dependent manner
- Open Access
- 4 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Genome-wide screening reveals a role for subcellular localization of CRBN in the anti-myeloma activity of pomalidomide
Pomalidomide, a derivative of thalidomide, is an effective treatment for multiple myeloma. The drug exerts its effects through CRBN, a component of the E3 ubiquitin ligase complex CRL4CRBN. To search for novel factors involved in the anti-cancer activity of pomalidomide, we performed a genome-wide shRNA library screen and identified 445 genes as those affecting pomalidomide sensitivity. Genes encoding components of the ubiquitin-proteasome pathway, such as subunits of the CRL4CRBN complex, the COP9 signalosome, and the 26S proteasome, were among the pomalidomide-affecting genes. Karyopherin beta 1 (KPNB1) was identified as a novel pomalidomide-affecting gene. KPNB1 was required for the nuclear import of CRBN and for the CRBN-directed, pomalidomide-dependent degradation of a clinically relevant substrate, the transcription factor Aiolos. By contrast, the cytoplasmic translation factor GSPT1 was degraded following treatment with the thalidomide derivative CC-885 only when CRBN was present in the cytoplasm, indicating that subcellular distribution of CRBN is critical for the efficacy of thalidomide-based medications.
- 4 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Open AccessGenome-wide screening reveals a role for subcellular localization of CRBN in the anti-myeloma activity of pomalidomide
Pomalidomide, a derivative of thalidomide, is an effective treatment for multiple myeloma. The drug exerts its effects through CRBN, a component of the E3 ubiquitin ligase complex CRL4CRBN. To search for novel factors involved in the anti-cancer activity of pomalidomide, we performed a genome-wide shRNA library screen and identified 445 genes as those affecting pomalidomide sensitivity. Genes encoding components of the ubiquitin-proteasome pathway, such as subunits of the CRL4CRBN complex, the COP9 signalosome, and the 26S proteasome, were among the pomalidomide-affecting genes. Karyopherin beta 1 (KPNB1) was identified as a novel pomalidomide-affecting gene. KPNB1 was required for the nuclear import of CRBN and for the CRBN-directed, pomalidomide-dependent degradation of a clinically relevant substrate, the transcription factor Aiolos. By contrast, the cytoplasmic translation factor GSPT1 was degraded following treatment with the thalidomide derivative CC-885 only when CRBN was present in the cytoplasm, indicating that subcellular distribution of CRBN is critical for the efficacy of thalidomide-based medications.
- Open Access
- 1 February 2020
- Published by AIP Publishing in AIP Advances
- Vol. 10 (2) , 025317
Development of an optimized dome-shaped magnet for rapid magnetic immunostaining
Magnetic immunostaining is a technique used to accelerate the antigen-antibody immunoreaction by increasing the local density of antibody on the surface of a tissue specimen using a magnetic field. The high density of antibody is achieved by applying a magnetic force to antibody-labeled ferrite beads toward the specimen. A technical challenge of using conventional magnets for this technique has been the inhomogeneous accumulation of magnetic beads on the specimen in accordance with the distribution of the magnetic field. Thus, in this study, a dome-shaped magnet that generated a strong and uniform magnetic force distribution was proposed and demonstrated. Numerical analysis was used to optimize the shape of the magnet. Analysis of the motion of magnetic beads showed that the accumulation of beads on the sample was complete within one minute and that the resulting homogeneity was sufficient for rapid and accurate immunostaining. Finally, experiments showed that the homogeneity of the bead distribution was improved by the use of a prototype dome-shaped magnet compared to conventional cylindrical magnets.
- 1 February 2020
- Published by AIP Publishing in AIP Advances
- Vol. 10 (2) , 025317
Open AccessDevelopment of an optimized dome-shaped magnet for rapid magnetic immunostaining
Magnetic immunostaining is a technique used to accelerate the antigen-antibody immunoreaction by increasing the local density of antibody on the surface of a tissue specimen using a magnetic field. The high density of antibody is achieved by applying a magnetic force to antibody-labeled ferrite beads toward the specimen. A technical challenge of using conventional magnets for this technique has been the inhomogeneous accumulation of magnetic beads on the specimen in accordance with the distribution of the magnetic field. Thus, in this study, a dome-shaped magnet that generated a strong and uniform magnetic force distribution was proposed and demonstrated. Numerical analysis was used to optimize the shape of the magnet. Analysis of the motion of magnetic beads showed that the accumulation of beads on the sample was complete within one minute and that the resulting homogeneity was sufficient for rapid and accurate immunostaining. Finally, experiments showed that the homogeneity of the bead distribution was improved by the use of a prototype dome-shaped magnet compared to conventional cylindrical magnets.
- Open Access
- 1 January 2020
- Published by AIP Publishing in AIP Advances
- Vol. 10 (1) , 015106
Development of an automatic magnetic immunostaining system for rapid intraoperative diagnosis of cancer metastasis
Magnetic immunostaining provides a novel technique for rapid intraoperative diagnosis of cancer metastasis and its characteristics in lymph nodes. Previous studies have shown the effectiveness of this technique using the manual staining process. However, to make this technique feasible for use in hospitals, establishing an automatic process is important. Thus, the objective of this study is to realize a device for immunostaining using magnetic fields that could not only automatically stain the samples, but also wash the specimen and change experimental solutions as well. The specifications for our prototype device were determined based on the manually performed experiments. We successfully fabricated a prototype device and demonstrated automatic immunostaining using it. The device completed, within 10 minutes, processes of blocking the specimen, injection of the magnetic beads, antigen-antibody reaction, and washing out the beads. The reaction took 1 minute, which was significantly shorter than that of conventional immunostaining. The device is expected to provide improved reproducibility of staining because of its automated processes.
- 1 January 2020
- Published by AIP Publishing in AIP Advances
- Vol. 10 (1) , 015106
Open AccessDevelopment of an automatic magnetic immunostaining system for rapid intraoperative diagnosis of cancer metastasis
Magnetic immunostaining provides a novel technique for rapid intraoperative diagnosis of cancer metastasis and its characteristics in lymph nodes. Previous studies have shown the effectiveness of this technique using the manual staining process. However, to make this technique feasible for use in hospitals, establishing an automatic process is important. Thus, the objective of this study is to realize a device for immunostaining using magnetic fields that could not only automatically stain the samples, but also wash the specimen and change experimental solutions as well. The specifications for our prototype device were determined based on the manually performed experiments. We successfully fabricated a prototype device and demonstrated automatic immunostaining using it. The device completed, within 10 minutes, processes of blocking the specimen, injection of the magnetic beads, antigen-antibody reaction, and washing out the beads. The reaction took 1 minute, which was significantly shorter than that of conventional immunostaining. The device is expected to provide improved reproducibility of staining because of its automated processes.
- Open Access
Cereblon Control of Zebrafish Brain Size by Regulation of Neural Stem Cell Proliferation
- Open Access
- 8 April 2019
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 67 (8) , 575-587
Magnetically Promoted Rapid Immunofluorescence Staining for Frozen Tissue Sections
Current immunohistochemistry methods for diagnosing abnormal cells, such as cancer cells, require multiple steps and can be relatively slow compared with intraoperative frozen hematoxylin and eosin staining, and are therefore rarely used for intraoperative examination. Thus, there is a need for novel rapid detection methods. We previously demonstrated that functionalized fluorescent ferrite beads (FF beads) magnetically promoted rapid immunoreactions. The aim of this study was to improve the magnetically promoted rapid immunoreaction method using antibody-coated FF beads and a magnet subjected to a magnetic field. Using frozen sections of xenograft samples of A431 human epidermoid cancer cells that express high levels of epidermal growth factor receptor (EGFR) and anti-EGFR antibody-coated FF beads, we reduced the magnetically promoted immunohistochemistry procedure to a 1-min reaction and 1-min wash. We also determined the optimum magnetic force for the antibody reaction (from 7.79 × 10−15 N to 3.35 × 10−15 N) and washing (4.78 × 10−16 N), which are important steps in this technique. Furthermore, we stained paraffin-embedded tissue arrays and frozen sections of metastatic breast cancer lymph nodes with anti-pan-cytokeratin antibody-coated FF beads to validate the utility of this system in clinical specimens. Under optimal conditions, this ultra-rapid immunostaining method may provide an ancillary method for pathological diagnosis during surgery. (J Histochem Cytochem 58:XXX–XXX, 2010)
- 8 April 2019
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 67 (8) , 575-587
Open AccessMagnetically Promoted Rapid Immunofluorescence Staining for Frozen Tissue Sections
Current immunohistochemistry methods for diagnosing abnormal cells, such as cancer cells, require multiple steps and can be relatively slow compared with intraoperative frozen hematoxylin and eosin staining, and are therefore rarely used for intraoperative examination. Thus, there is a need for novel rapid detection methods. We previously demonstrated that functionalized fluorescent ferrite beads (FF beads) magnetically promoted rapid immunoreactions. The aim of this study was to improve the magnetically promoted rapid immunoreaction method using antibody-coated FF beads and a magnet subjected to a magnetic field. Using frozen sections of xenograft samples of A431 human epidermoid cancer cells that express high levels of epidermal growth factor receptor (EGFR) and anti-EGFR antibody-coated FF beads, we reduced the magnetically promoted immunohistochemistry procedure to a 1-min reaction and 1-min wash. We also determined the optimum magnetic force for the antibody reaction (from 7.79 × 10−15 N to 3.35 × 10−15 N) and washing (4.78 × 10−16 N), which are important steps in this technique. Furthermore, we stained paraffin-embedded tissue arrays and frozen sections of metastatic breast cancer lymph nodes with anti-pan-cytokeratin antibody-coated FF beads to validate the utility of this system in clinical specimens. Under optimal conditions, this ultra-rapid immunostaining method may provide an ancillary method for pathological diagnosis during surgery. (J Histochem Cytochem 58:XXX–XXX, 2010)
- Open Access
- 9 January 2019
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 411 (9) , 1825-1837
Application of high-performance magnetic nanobeads to biological sensing devices
Nanomaterials have extensive applications in the life sciences and in clinical diagnosis. We have developed magnetic nanoparticles with high dispersibility and extremely low nonspecific binding to biomolecules and have demonstrated their application in chemical biology (e.g., for the screening of drug receptor proteins). Recently, the excellent properties of nanobeads have made possible the development of novel rapid immunoassay systems and high-precision technologies for exosome detection. For immunoassays, we developed a technology to encapsulate a fluorescent substance in magnetic nanobeads. The fluorescent nanobeads allow the rapid detection of a specific antigen in solution or in tissue specimens. Exosomes, which are released into the blood, are expected to become markers for several diseases, including cancer, but techniques for measuring the absolute quantity of exosomes in biological fluids are lacking. By integrating magnetic nanobead technology with an optical disc system, we developed a novel method for precisely quantifying exosomes in human serum with high sensitivity and high linearity without requiring enrichment procedures. This review focuses on the properties of our magnetic nanobeads, the development of novel biosensors using these nanobeads, and their broad practical applications. Graphical abstract
- 9 January 2019
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 411 (9) , 1825-1837
Open AccessApplication of high-performance magnetic nanobeads to biological sensing devices
Nanomaterials have extensive applications in the life sciences and in clinical diagnosis. We have developed magnetic nanoparticles with high dispersibility and extremely low nonspecific binding to biomolecules and have demonstrated their application in chemical biology (e.g., for the screening of drug receptor proteins). Recently, the excellent properties of nanobeads have made possible the development of novel rapid immunoassay systems and high-precision technologies for exosome detection. For immunoassays, we developed a technology to encapsulate a fluorescent substance in magnetic nanobeads. The fluorescent nanobeads allow the rapid detection of a specific antigen in solution or in tissue specimens. Exosomes, which are released into the blood, are expected to become markers for several diseases, including cancer, but techniques for measuring the absolute quantity of exosomes in biological fluids are lacking. By integrating magnetic nanobead technology with an optical disc system, we developed a novel method for precisely quantifying exosomes in human serum with high sensitivity and high linearity without requiring enrichment procedures. This review focuses on the properties of our magnetic nanobeads, the development of novel biosensors using these nanobeads, and their broad practical applications. Graphical abstract
- Open Access
- 22 June 2018
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 215 (8) , 2197-2209
NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation
NAD(P)H:quinone oxidoreductase 1 (NQO1) protects cells against oxidative stress and toxic quinones. In this study, we found a novel role of NQO1 in suppressing Toll-like receptor (TLR)–mediated innate immune responses. NQO1-deficient macrophages selectively produced excessive amounts of IL-6, IL-12, and GM-CSF on LPS stimulation, and the deletion of NQO1 in macrophages exacerbated LPS-induced septic shock. NQO1 interacted with the nuclear IκB protein IκB-ζ, which is essential for the TLR-mediated induction of a subset of secondary response genes, including IL-6, and promoted IκB-ζ degradation in a ubiquitin-dependent manner. We demonstrated that PDLIM2, known as the ubiquitin E3 ligase, participates in NQO1-dependent IκB-ζ degradation. NQO1 augmented the association between PDLIM2 and IκB-ζ, resulting in increased IκB-ζ degradation. Collectively, this study describes a mechanism of the NQO1–PDLIM2 complex as a novel and important regulator in the innate immune signaling and suggests the therapeutic potential of NQO1 in TLR-mediated inflammation and disorders.
- 22 June 2018
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 215 (8) , 2197-2209
Open AccessNQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation
NAD(P)H:quinone oxidoreductase 1 (NQO1) protects cells against oxidative stress and toxic quinones. In this study, we found a novel role of NQO1 in suppressing Toll-like receptor (TLR)–mediated innate immune responses. NQO1-deficient macrophages selectively produced excessive amounts of IL-6, IL-12, and GM-CSF on LPS stimulation, and the deletion of NQO1 in macrophages exacerbated LPS-induced septic shock. NQO1 interacted with the nuclear IκB protein IκB-ζ, which is essential for the TLR-mediated induction of a subset of secondary response genes, including IL-6, and promoted IκB-ζ degradation in a ubiquitin-dependent manner. We demonstrated that PDLIM2, known as the ubiquitin E3 ligase, participates in NQO1-dependent IκB-ζ degradation. NQO1 augmented the association between PDLIM2 and IκB-ζ, resulting in increased IκB-ζ degradation. Collectively, this study describes a mechanism of the NQO1–PDLIM2 complex as a novel and important regulator in the innate immune signaling and suggests the therapeutic potential of NQO1 in TLR-mediated inflammation and disorders.
- Open Access
- 24 January 2018
- Published by AIP Publishing in AIP Advances
- Vol. 8 (5) , 056732
Development of magnet configurations for magnetic immunostaining
Magnetic immunostaining using a magnet and antibody-labeled fluorescent ferrite (FF) beads is established as a rapid immunostaining. In this study, we proposed the novel configuration of magnets with the large magnetic field gradient and the strong magnetic force for magnetic immunostaining. To confirm the usefulness of the proposed magnet configuration, we performed numerical analysis of the magnetic characteristics of the proposed magnets, and the magnetic immunostaining with FF beads. It was revealed that the proposed magnets generated the strong magnetic force and promoted the immunoreaction rapidly.
- 24 January 2018
- Published by AIP Publishing in AIP Advances
- Vol. 8 (5) , 056732
Open AccessDevelopment of magnet configurations for magnetic immunostaining
Magnetic immunostaining using a magnet and antibody-labeled fluorescent ferrite (FF) beads is established as a rapid immunostaining. In this study, we proposed the novel configuration of magnets with the large magnetic field gradient and the strong magnetic force for magnetic immunostaining. To confirm the usefulness of the proposed magnet configuration, we performed numerical analysis of the magnetic characteristics of the proposed magnets, and the magnetic immunostaining with FF beads. It was revealed that the proposed magnets generated the strong magnetic force and promoted the immunoreaction rapidly.